User profiles for Derek T. Larson
 | Derek T. LarsonAssistant Professor, Uniformed Services University Verified email at health.mil Cited by 804 |
[PDF][PDF] Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history
…, DA Lindholm, K Mende, EC Ewers, DT Larson… - Cell host & …, 2022 - cell.com
The rapid emergence of SARS-CoV-2 variants challenges vaccination strategies. Here, we
collected 201 serum samples from persons with a single infection or multiple vaccine …
collected 201 serum samples from persons with a single infection or multiple vaccine …
Synergistic interactions of TLR2/6 and TLR9 induce a high level of resistance to lung infection in mice
Infectious pneumonias exact an unacceptable mortality burden worldwide. Efforts to protect
populations from pneumonia have focused historically on antibiotic development and vaccine…
populations from pneumonia have focused historically on antibiotic development and vaccine…
Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi
…, BL Scott, CG Clement, DT Larson… - American journal of …, 2010 - atsjournals.org
Pneumonia is a serious problem worldwide. We recently demonstrated that innate defense
mechanisms of the lung are highly inducible against pneumococcal pneumonia. To …
mechanisms of the lung are highly inducible against pneumococcal pneumonia. To …
[PDF][PDF] The SARS-CoV-2 mRNA vaccine breakthrough infection phenotype includes significant symptoms, live virus shedding, and viral genetic diversity
…, S Chi, R Mody, C Madar, A Ganesan, DT Larson… - Clin Infect …, 2021 - scholar.archive.org
Little is known about SARS-CoV-2 ‘vaccine-breakthrough’infections (VBI). Here we characterize
24 VBI in predominantly young healthy persons. While none required hospitalization, a …
24 VBI in predominantly young healthy persons. While none required hospitalization, a …
[HTML][HTML] Understanding'hybrid immunity': comparison and predictors of humoral immune responses to SARS-CoV-2 infection and COVID-19 vaccines.
BACKGROUND: Comparing humoral responses in SARS-CoV-2 vaccinees, those with
SARS-CoV-2 infection, or combinations of vaccine/infection ('hybrid immunity'), may clarify …
SARS-CoV-2 infection, or combinations of vaccine/infection ('hybrid immunity'), may clarify …
Persistent COVID-19 symptoms at 6 months after onset and the role of vaccination before or after SARS-CoV-2 infection
…, CJ Colombo, C Madar, M Jones, DT Larson… - JAMA network …, 2023 - jamanetwork.com
Importance Understanding the factors associated with post-COVID conditions is important
for prevention. Objective To identify characteristics associated with persistent post–COVID-19 …
for prevention. Objective To identify characteristics associated with persistent post–COVID-19 …
SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity
…, DT Larson, RE Colombo, S Chi, C Madar, T Lalani… - medrxiv, 2021 - medrxiv.org
Importance The persistence of SARS-CoV-2 antibodies may be a predictive correlate of
protection for both natural infections and vaccinations. Identifying predictors of robust antibody …
protection for both natural infections and vaccinations. Identifying predictors of robust antibody …
COVID-19 outcomes among US Military Health System beneficiaries include complications across multiple organ systems and substantial functional impairment
…, C Madar, S Chi, N Huprikar, DT Larson… - Open Forum …, 2021 - academic.oup.com
Background We evaluated clinical outcomes, functional burden, and complications 1 month
after coronavirus disease 2019 (COVID-19) infection in a prospective US Military Health …
after coronavirus disease 2019 (COVID-19) infection in a prospective US Military Health …
Understanding “hybrid immunity”: comparison and predictors of humoral immune responses to severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV …
Background Comparison of humoral responses in severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) vaccinees, those with SARS-CoV-2 infection, or combinations of …
coronavirus 2 (SARS-CoV-2) vaccinees, those with SARS-CoV-2 infection, or combinations of …
Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) instrument in patients with coronavirus disease 2019
…, SW Chi, N Huprikar, DT Larson… - Open Forum …, 2021 - academic.oup.com
Background The inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) is a patient-reported
outcome data collection instrument assessing symptoms of viral respiratory tract …
outcome data collection instrument assessing symptoms of viral respiratory tract …